Akihiro Yamada

4PUBLICATIONS
7CO-AUTHORS
ChemotherapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 19, 2025
Population pharmacokinetic analysis of fluorouracil and oxaliplatin in the absence or presence of zolbetuximab in locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.

Akihiro Yamada, Jianning Yang, Peter L Bonate

|Aug 14, 2025
Clinical Pharmacology Profile of the Claudin 18.2 Antibody Zolbetuximab.

Jianning Yang, Akihiro Yamada, Kohei Shitara

|Jul 03, 2025
Population PK and Exposure-Response Analyses of Zolbetuximab in Patients With Locally Advanced Unresectable or Metastatic G/GEJ Adenocarcinoma.

Akihiro Yamada, Masato Takeuchi, Kanji Komatsu

|Jan 08, 2025
A Multiple-Model-Informed Drug-Development Approach for Optimal Regimen Selection of an Oncolytic Virus in Combination With Pembrolizumab.

Akihiro Yamada, Mary P Choules, Frances A Brightman

Pageof 1

Frequent Collaborators

1 joint publications

Mary P Choules

1 joint publications

Frances A Brightman

1 joint publications

Shinsuke Nakao

1 joint publications

Hitesh Mistry